STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
Hello, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies hovering over the unusually quiet Pharmalot campus. While the sun may not be shining, we will
